244 related articles for article (PubMed ID: 19136769)
61. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma].
Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Li L; Luo XL
Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292
[TBL] [Abstract][Full Text] [Related]
62. Anaplastic large cell lymphoma, CD30/Ki-1 positive, expressing the CD15/Leu-M1 antigen. Immunohistochemical and morphological relationships to Hodgkin's disease.
Rosso R; Paulli M; Magrini U; Kindl S; Boveri E; Volpato G; Poggi S; Baglioni P; Pileri S
Virchows Arch A Pathol Anat Histopathol; 1990; 416(3):229-35. PubMed ID: 1967860
[TBL] [Abstract][Full Text] [Related]
63. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.
Bräuninger A; Wacker HH; Rajewsky K; Küppers R; Hansmann ML
Cancer Res; 2003 Apr; 63(7):1644-51. PubMed ID: 12670918
[TBL] [Abstract][Full Text] [Related]
64. Chronic lymphocytic leukemia with coexistent Hodgkin's disease. Implications for the origin of the Reed-Sternberg cell.
Williams J; Schned A; Cotelingam JD; Jaffe ES
Am J Surg Pathol; 1991 Jan; 15(1):33-42. PubMed ID: 1670753
[TBL] [Abstract][Full Text] [Related]
65. [Hodgkin's and Reed-Sternberg cells in the peripheral blood of a patient with advanced stage Hodgkin's disease].
Milosević R; Colović M; Cemerikić-Martinović V; Colović N; Bogunović M
Srp Arh Celok Lek; 2003; 131(9-10):400-2. PubMed ID: 15058220
[TBL] [Abstract][Full Text] [Related]
66. Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.
Marafioti T; Mancini C; Ascani S; Sabattini E; Zinzani PL; Pozzobon M; Pulford K; Falini B; Jaffe ES; Müller-Hermelink HK; Mason DY; Pileri SA
Haematologica; 2004 Aug; 89(8):957-64. PubMed ID: 15339679
[TBL] [Abstract][Full Text] [Related]
67. CD20 role in pathophysiology of Hodgkin's disease.
Santos MAO; Lima MM
Rev Assoc Med Bras (1992); 2017 Sep; 63(9):810-813. PubMed ID: 29239464
[TBL] [Abstract][Full Text] [Related]
68. CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD).
Jacob MC; Favre M; Lemarc'Hadour F; Sotto MF; Bonnefoix T; Sotto JJ; Bensa JC
Am J Hematol; 1992 Jan; 39(1):45-51. PubMed ID: 1531569
[TBL] [Abstract][Full Text] [Related]
69. Yttrium-90 ibritumomab tiuxetan-induced complete remission in a patient with classical lymphocyte-rich Hodgkin's Lymphoma.
Schnell R; Dietlein M; Schomäcker K; Kobe C; Borchmann P; Schicha H; Hallek M; Engert A
Onkologie; 2008 Feb; 31(1-2):49-51. PubMed ID: 18268399
[TBL] [Abstract][Full Text] [Related]
70. CD30 differential staining is useful in classifying lymphomas intermediate between Hodgkin's disease and anaplastic large cell (Ki1) lymphoma.
Schmidt U; Metz KA; Möser U
Tumori; 1998; 84(6):695-700. PubMed ID: 10080680
[TBL] [Abstract][Full Text] [Related]
71. The immunophenotype of Reed-Sternberg cells. A study of 50 cases of Hodgkin's disease using fixed frozen tissues.
Agnarsson BA; Kadin ME
Cancer; 1989 Jun; 63(11):2083-7. PubMed ID: 2566368
[TBL] [Abstract][Full Text] [Related]
72. Clinicopathological significance of CD79a expression in classic Hodgkin lymphoma.
Sakatani A; Igawa T; Okatani T; Fujihara M; Asaoku H; Sato Y; Yoshino T
J Clin Exp Hematop; 2020 Sep; 60(3):78-86. PubMed ID: 32641598
[TBL] [Abstract][Full Text] [Related]
73. Primary gastric Hodgkin's lymphoma expressing a B-Cell profile including Oct-2 and Bob-1 proteins.
Saito M; Tanaka S; Mori A; Toyoshima N; Irie T; Morioka M
Int J Hematol; 2007 Jun; 85(5):421-5. PubMed ID: 17562619
[TBL] [Abstract][Full Text] [Related]
74. Chronic lymphocytic leukemia/small lymphocytic lymphoma with Reed-Sternberg-like cells and possible transformation to Hodgkin's disease. Mediation by Epstein-Barr virus.
Momose H; Jaffe ES; Shin SS; Chen YY; Weiss LM
Am J Surg Pathol; 1992 Sep; 16(9):859-67. PubMed ID: 1384376
[TBL] [Abstract][Full Text] [Related]
75. Correlation between presence of clonal rearrangements of immunoglobulin heavy chain genes and B-cell antigen expression in Hodgkin's disease.
Orazi A; Jiang B; Lee CH; English GW; Cattoretti G; John K; Neiman RS
Am J Clin Pathol; 1995 Oct; 104(4):413-8. PubMed ID: 7572791
[TBL] [Abstract][Full Text] [Related]
76. MMA monoclonal antibody is a superior anti-CD15 reagent for the diagnosis of classical Hodgkin's lymphoma?
Pellegrini W; Bresciani G; De Zorzi A; Marocolo D; Ungari M; Facchetti F
Haematologica; 2007 May; 92(5):708-9. PubMed ID: 17488702
[TBL] [Abstract][Full Text] [Related]
77. CD30 expression in non-Hodgkin's lymphoma.
Piris M; Brown DC; Gatter KC; Mason DY
Histopathology; 1990 Sep; 17(3):211-8. PubMed ID: 2173674
[TBL] [Abstract][Full Text] [Related]
78. Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features.
Achten R; Verhoef G; Vanuytsel L; De Wolf-Peeters C
Histopathology; 2002 Jan; 40(1):31-45. PubMed ID: 11903596
[TBL] [Abstract][Full Text] [Related]
79. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
[TBL] [Abstract][Full Text] [Related]
80. T-cell variant of classical Hodgkin's lymphoma with nodal and cutaneous manifestations demonstrated by single-cell polymerase chain reaction.
Willenbrock K; Ichinohasama R; Kadin ME; Miura I; Terui T; Meguro K; Fukuhara O; DeCoteau JF; Hansmann ML
Lab Invest; 2002 Sep; 82(9):1103-9. PubMed ID: 12218070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
